Abstract:Background Gut microbiota and its metabolites are important factors affecting the treatment and progression of ulcerative colitis, but the mechanism was still unclear. This study aims to study the efficacy of Clostridium butyricum MIYAIRI 588 (CBM) on colitis mice and explore the effect on IgA-coated microbiota of CBM and metabolite butyrate. Methods Twenty-four Balb/c mice with specific pathogen-free were randomly divided into four groups of six mice each. The Control group were fed normal drinking water, and the other three groups were drinking water which contained 3% DSS for seven days. In this study, CBM (106CFU/mL) and its main metabolite butyrate (0.2mg/kg) were used to intervene in the colitis mouse by oral gavage. The changes in weight loss, colon length and histopathology of colitis mice were observed and recorded. RNA-sequencing was used to detect the transcriptional changes in the colon in mice, and the percentage of IgA-coated microbiota in feces was detected by flow cytometry. Results From the fourth day after the intervention of CBM and butyrate, the weight loss and colon shorten of colitis mice had been alleviated (IDDF2022-ABS-0275 Figure 1A. Weight loss of mice after CBM and butyrate treatment) (IDDF2022-ABS-0275 Figure 1B. Colon length of mice). Besides, CBM and metabolite butyrate can relieve the colonic pathology, which is reflected in reducing the damage of the mucosa structure and the infiltration of inflammatory cells (IDDF2022-ABS-0275 Figure 1C. Histopathological analysis of colon sections which stained by hematoxylin-eosin staining). RNA-sequencing showed that by KEGG enrichment analysis of differentially expressed genes, numerous signaling pathways concerning immunity and metabolism could be observed, including the pathway of the intestinal immune network for IgA production (IDDF2022-ABS-0275 Figure 1D. KEGG enrichment analysis of butyrate treatment on colitis mice). Furthermore, results showed that the proportion of IgA-coated microbiota in cecal contents of mice with colitis increased significantly. However, both CBM and metabolite butyrate could significantly reduce the proportion of IgA-coated microbiota (IDDF2022-ABS-0275 Figure 1E. The proportion of IgA-coated microbiota after CBM and butyrate treatment) (IDDF2022-ABS-0275 Figure 1F. The statistical analysis of the percentage of IgA-coated microbiota). Conclusions The present study confirmed that CBM and metabolite butyrate could effectively alleviate DSS-induced colitis, might through regulating mucosal immune homeostasis by affecting IgA-coated microbiota. In summary, our study explored the interaction between gut microbiota and host immunity, and it provides theoretical support for the better use of probiotics.

The Pivotal Role of Aryl Hydrocarbon Receptor-Regulated Tight Junction Proteins and Innate Immunity on the Synergistic Effects of Postbiotic Butyrate and Active Vitamin D3 to Defense against Microbial Invasion in Salmonella Colitis

Gut microbiota modulation and anti-inflammatory properties of mixed lactobacilli in dextran sodium sulfate-induced colitis in mice

Microbiota Metabolite Short-Chain Fatty Acids Facilitate Mucosal Adjuvant Activity of Cholera Toxin Through GPR43

Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating AHR/NRF2/NLRP3 Inflammasome Pathways through Indole-3-lactic Acid Production

Lactobacillus acidophilus attenuates Salmonella -induced intestinal inflammation via TGF-β signaling

Novel Synergistic Probiotic Intervention: Transcriptomic and Metabolomic Analysis Reveals Ameliorative Effects on Immunity, Gut Barrier, and Metabolism of Mice during Salmonella typhimurium Infection

Bifidobacterium bifidum H3-R2 and Its Molecular Communication within the Context of Ulcerative Colitis

<i>Bifidobacterium bifidum</i> H3-R2 and Its Molecular Communication within the Context of Ulcerative Colitis

Immunomodulatory Effects of Lactiplantibacillus plantarum Strain RW1 During Salmonella Infection in Murine Intestinal Epithelial Cells and Dextran Sulfate Sodium-Induced Murine Colitis

Unveiling the Novel Benefits of Co-Administering Butyrate and Active Vitamin D3 in Mice Subjected to Chemotherapy-Induced Gut-Derived Pseudomonas aeruginosa Sepsis

Deciphering Microbiome, Transcriptome, and Metabolic Interactions in the Presence of Probiotic Lactobacillus acidophilus against Salmonella Typhimurium in a Murine Model

Phlorotannins Isolated from Eisenia bicyclis and Lactobacillus casei Ameliorate Dextran Sulfate Sodium-Induced Colitis in Mice through the AhR Pathway

Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis

Alterations in Intestinal Microbiota Composition in Mice Treated With Vitamin D3 or Cathelicidin

P036 Microbiota Metabolite Butyrate Attenuates Intestinal Inflammation Through Autophagy Activation

Clostridium butyricum Ameliorates Salmonella Enteritis Induced Inflammation by Enhancing and Improving Immunity of the Intestinal Epithelial Barrier at the Intestinal Mucosal Level

IDDF2022-ABS-0275 Clostridium Btyricum and Metabolite Butyrate Relieve DSS-induced Colitis in Mice by Regulating IGA-coated Microbiota

Epithelial aryl hydrocarbon receptor regulates IL-22 producing colonic group 3 innate lymphoid cells to augment microbial metabolite mediated protection in colitis

Dietary pectin attenuates Salmonella typhimurium -induced colitis by modulating the TLR2-NF-κB pathway and intestinal microbiota in mice

Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis

Effects of Clostridium butyricum on intestinal environment and gut microbiome under Salmonella infection